TrialAllergy2017

A randomized controlled phase II clinical trial comparing ONO-4053, a novel DP1 antagonist, with a leukotriene receptor antagonist pranlukast in patients with seasonal allergic rhinitis.

K Okubo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.